UpdatesCompany Update
The company has announced a board meeting on Monday, November 13, 2023. The agenda includes approving the financial results for the quarter and half-year.
Welcure Drugs & Pharmaceuticals Ltd524661 · Filed with the exchange
The Board will also consider a fundraising proposal, potentially through a Preferential Issue of Warrants convertible into Equity Shares.
Other methods like a Rights Issue, Qualified Institutions Placement (QIP), or Private Placement may also be explored.
Additionally, the meeting will discuss the appointment of an Independent Director and a Chief Financial Officer, signaling key leadership changes.
No comments yet. Be the first.